Drug Shortage Report for CLINDAMYCIN INJECTION USP

Last updated on 2021-05-03 History
Report ID 136503
Drug Identification Number 02230540
Brand name CLINDAMYCIN INJECTION USP
Common or Proper name CLINDAMYCIN INJECTION USP
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) CLINDAMYCIN
Strength(s) 150MG
Dosage form(s) LIQUID
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 6ML 10 LVI V2 CA
ATC code J01FF
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2021-03-26
Estimated end date 2021-05-21
Actual end date
Shortage status Actual shortage
Updated date 2021-05-03
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-05-03 French Compare
v3 2021-05-03 English Compare
v2 2021-03-29 French Compare
v1 2021-03-29 English Compare